Thermo Fisher (TMO) Extends Collaboration With Symphogen
4/3 13:45
Thermo Fisher Scientific, Inc. TMO recently announced the continuation of its collaboration with Symphogen -- a clinical-stage antibody oncology-focused company, pioneering the application of complex mAb mixtures for cancer therapy. The extension of the collaboration is i...